Anteris Technologies Global Corp. Common Stock (AVR) - Net Assets
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) has net assets worth $278.41 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($294.72 Million) and total liabilities ($16.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AVR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $278.41 Million |
| % of Total Assets | 94.47% |
| Annual Growth Rate | N/A |
| 5-Year Change | -102.4% |
| 10-Year Change | N/A |
| Growth Volatility | 198.94 |
Anteris Technologies Global Corp. Common Stock - Net Assets Trend (2020–2025)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's net assets have evolved over time, based on quarterly financial data. See Anteris Technologies Global Corp. Common (AVR) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Anteris Technologies Global Corp. Common Stock (2020–2025)
The table below shows the annual net assets of Anteris Technologies Global Corp. Common Stock from 2020 to 2025. For live valuation and market cap data, see Anteris Technologies Global Corp. Common (AVR) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-253.00K | -100.40% |
| 2024-12-31 | $62.68 Million | +231.68% |
| 2023-12-31 | $18.90 Million | +109.21% |
| 2022-12-31 | $9.03 Million | -14.17% |
| 2021-12-31 | $10.52 Million | +467.08% |
| 2020-12-31 | $1.86 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Anteris Technologies Global Corp. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 26662099000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | % |
| Other Comprehensive Income | $-10.28 Million | % |
| Other Components | $380.71 Million | % |
| Total Equity | $-93.00K | 100.00% |
Anteris Technologies Global Corp. Common Stock Competitors by Market Cap
The table below lists competitors of Anteris Technologies Global Corp. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Center International Group Co Ltd
SHG:603098
|
$924.80 Million |
|
Huangshan Novel Co Ltd
SHE:002014
|
$924.95 Million |
|
Amtran Technology Co Ltd
TW:2489
|
$925.36 Million |
|
Yunnan QuakeSafe Seismic Isolation Technologies Co Ltd Class A
SHE:300767
|
$925.44 Million |
|
TOA PAINT (THAILAND)
BK:TOA-R
|
$924.49 Million |
|
ZoomInfo Technologies Inc.
NASDAQ:GTM
|
$924.24 Million |
|
Juewei Food Co Ltd
SHG:603517
|
$924.02 Million |
|
Xian Peri Power Semiconductor Cond
SHE:300831
|
$923.88 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Anteris Technologies Global Corp. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 62,761,000 to -93,000, a change of -62,854,000 (-100.1%).
- Net loss of 94,144,000 reduced equity.
- Other comprehensive income increased equity by 615,000.
- Other factors increased equity by 30,675,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-94.14 Million | -101230.11% |
| Other Comprehensive Income | $615.00K | +661.29% |
| Other Changes | $30.68 Million | +32983.87% |
| Total Change | $- | -100.15% |
Book Value vs Market Value Analysis
This analysis compares Anteris Technologies Global Corp. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.05 | $9.78 | x |
| 2021-12-31 | $0.29 | $9.78 | x |
| 2022-12-31 | $0.25 | $9.78 | x |
| 2023-12-31 | $0.54 | $9.78 | x |
| 2024-12-31 | $3.10 | $9.78 | x |
| 2025-12-31 | $0.00 | $9.78 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Anteris Technologies Global Corp. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4921.28%
- • Asset Turnover: 0.08x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-249.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -634.53% | -215.78% | 0.56x | 5.26x | $-11.96 Million |
| 2021 | -163.15% | -294.50% | 0.27x | 2.04x | $-18.22 Million |
| 2022 | -338.35% | -954.91% | 0.20x | 1.77x | $-31.47 Million |
| 2023 | -238.44% | -1682.81% | 0.09x | 1.58x | $-47.95 Million |
| 2024 | -121.56% | -2822.46% | 0.03x | 1.29x | $-82.57 Million |
| 2025 | 0.00% | -4921.28% | 0.08x | 0.00x | $-94.13 Million |
Industry Comparison
This section compares Anteris Technologies Global Corp. Common Stock's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,122,883,573
- Average return on equity (ROE) among peers: -18.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Anteris Technologies Global Corp. Common Stock (AVR) | $278.41 Million | -634.53% | 0.06x | $924.75 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $64.44 Million |
| Align Technology Inc (ALGN) | $3.62 Billion | 21.31% | 0.64x | $12.09 Billion |
| AngioDynamics Inc (ANGO) | $523.39 Million | -0.99% | 0.39x | $447.90 Million |
| AptarGroup Inc (ATR) | $424.40 Million | 13.83% | 1.03x | $7.66 Billion |
| AtriCure Inc (ATRC) | $29.12 Million | -34.92% | 0.49x | $1.38 Billion |
| Avinger Inc (AVGR) | $13.08 Million | -151.60% | 1.54x | $1.52 Million |
| Avantor Inc (AVTR) | $-510.60 Million | 0.00% | 0.00x | $5.44 Billion |
| Azenta Inc (AZTA) | $2.53 Billion | -0.56% | 0.14x | $1.07 Billion |
| Baxter International Inc (BAX) | $3.35 Billion | 23.81% | 1.88x | $9.94 Billion |
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT ant… Read more